The immunomodulatory properties of hAECs likely underlie the beneficial effects of hAECs in large animal models of perinatal lung and brain injury [11, 12, 54], in which IL-1 and IL-6 expression are reduced [11, 12]. The gene discussed is IL1A; the disease is injury.